Europe Cell Line Development Market Growth and Recent Trends by 2027

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027

Europe Cell Line Development Market to 2027 - Regional Analysis and Forecasts by Type (Primary Cell Line, Hybridomas, Continuous Cell Lines, and Recombinant Cell Line); By Product (Equipment and Media & Reagent); Application (Drug Discovery, Bioproduction and Tissue Engineering); and Geography

  • Report Date : Mar 2020
  • Report Code : TIPRE00009032
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 114
Page Updated: Apr 2021

The Europe cell line development market is expected to reach US$ 3,187.57 million in 2027 from US$ 1,214.01 million in 2019. The market is estimated to grow with a CAGR of 13.0% from 2020-2027.

The cell line is established cell culture, which gets increased numerous times when supplied with the growth medium and space for growth. Different cell lines can be made from different cells. The cell line plays a vital role in the study of cytology. The cell line enables stepwise alterations in the structure, physiology, and genetic makeup of cells under a customized environment.The scope of the cell line development market includes type, product, application, and region.


Europe cell line development market
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

EUROPE CELL LINE DEVELOPMENT MARKET SEGMENTATION

By Type

  • Primary Cell Line
  • Hybridomas
  • Continuous Cell Lines
  • Recombinant Cell Line

 

By Product

  • Equipment
  • Media & Reagent

 

By Application

  • Drug Discovery
  • Bioproduction
  • Tissue Engineering

By Country

  •  Europe

    •  Germany
    •  UK
    •  France
    •  Spain
    •  Italy
    •  Rest of Europe

Company Profiles

  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • SELEXIS
  • WuXiAppTec
  • General Electric
  • Lonza
  • Corning Incorporated

Europe Cell Line Development Report Scope

Report Attribute Details
Market size in 2019 US$ 1,214.01 Million
Market Size by 2027 US$ 3,187.57 Million
Global CAGR (2020 - 2027) 13.0%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Type
  • Primary Cell Line
  • Hybridomas
  • Continuous Cell Lines
  • Recombinant Cell Line
By Product
  • Equipment and Media & Reagent
By Application
  • Drug Discovery
  • Bioproduction and Tissue Engineering
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • SELEXIS
  • WuXiAppTec
  • General Electric
  • Lonza
  • Corning Incorporated
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Our Clients
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Email: sales@theinsightpartners.com
Chat with us
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015
ISO Certified Logo